GRANTS

367 RESULTS

To submit a grant posting, please fill out our web form or download the form so that you can email us at grants@alzforum.org. List the sponsor name, amount, due date, and contact information. This is a free service.

Please Note: We remove grant postings after 6 months. If you would like your listing to be posted longer or taken down sooner, please contact us at grants@alzforum.org.

Novel Approaches for Relating Genetic Variation to Function and Disease (R21 Clinical Trial Not Allowed)

Sponsor: National Human Genome Research Institute

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Novel Approaches for Relating Genetic Variation to Function and Disease (R01 Clinical Trial Not Allowed)

Sponsor: National Human Genome Research Institute National Institute of Mental Health

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

BRAIN Initiative: Development Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (STTR) (R41/R42 - Clinical Trials Not Allowed)

Sponsor: National Institutes of Health

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. *** Note new SBIR/STTR Standard Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

BRAIN Initiative: Development Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR) (R43/R44 - Clinical Trial Not Allowed)

Sponsor: National Institutes of Health

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. *** Note new SBIR/STTR Standard Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Early Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Optional)

Sponsor: National Institute on Aging National Institute of Nursing Research

Award: NIH intends to fund an estimate of 10-15 awards, corresponding to a total of $10 million, for fiscal year 2019. Future year amounts will depend on annual appropriations.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Late Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Required)

Sponsor: National Institute on Aging

Award: NIH intends to fund an estimate of eight to 10 awards, corresponding to a total of $25 million, for fiscal year 2019. Future year amounts will depend on annual appropriations.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional)

Sponsor: National Institutes of Health

Award: Issuing IC and partner components intend to commit an estimated total of $3 million to fund three to five new awards at each receipt date. It is expected that costs will be substantially higher after the first year of these awards.

Due Date: September 27, 2018, and September 6, 2019, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed)

Sponsor: National Institutes of Health

Award: Issuing IC and partner components intend to commit an estimated total of $4 million to fund 10 awards.

Due Date: September 27, 2018; March 7, 2019; September 6, 2019; March 6, 2020; September 9, 2020; March 4, 2021 by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

The Jackson Laboratory 2018 Pilot Project Awards

Sponsor: Nathan Shock Center for Excellence in the Basic Biology of Aging

Due Date: Opportunities for phenotyping, intervention testing, and tissue collection with aged mice require advanced planning. Applications received by October 1, 2018 will be considered together in the annual planning cycle. However, applications will also be considered on a year-round basis. Information about specific opportunities will be posted on nathanshockcenters.org and at agingmice.jax.org. Upon approval, pilot projects will start as soon as the required mice or resources become available.

The National Health and Aging Trends Study (U01 Clinical Trial Not Allowed)

Sponsor: National Institute on Aging

Award: NIA intends to commit $8.78 million in total costs in FY 2019, and $45 million in total costs over five years, to fund one award.

Due Date: October 1, 2018, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Current Filters

No filters selected

Filter By